Breast Cancer Risk Assessment and Personalized Screening Program at RUSH MD Anderson With Lisa Stempel, MD

RUSH MD Anderson Cancer Center’s Breast Cancer Risk Assessment and Personalized Screening Program incorporates sophisticated diagnostic and therapeutic tools that Lisa Stempel, MD, and her colleagues use to determine the most effective care pathway for patients who are at high risk for breast cancer.

Dr. Stempel is a diagnostic radiologist at RUSH MD Anderson. She is chief of the Division of Breast Imaging and director of the High-Risk Cancer Screening Program at RUSH MD Anderson.

“Screening mammography is a great model we can use for early detection for other types of cancers. For example, if we can catch breast cancer in its early stages, say stage 0 or 1, there’s a 99.9% cure rate. Even if it's stage 2, we have a 93% cure rate. Early detection applies to almost all types of cancers, too. What we’ve learned is that with mammography and the addition of supplemental screening tests, we can find breast cancer at the earliest stages.”